- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.08. | Daily Special: Chilwa Minerals, Osteopore, DeSoto Resources, Sabre Resources, Somerset Minerals | 5 | Finance News Network | ||
| 06.08. | Osteopore (ASX:OSX) signs 3-year GCC deal targeting a US$1.55bn orthopaedic market | - | Stocks Down Under | ||
| 06.08. | OSTEOPORE LIMITED: OSX strikes orthopaedic deal for 5 Middle East countries | 1 | ASX | ||
| 03.08. | OSTEOPORE LIMITED: Details of Auditor Appointment/Resignation | - | ASX | ||
| 03.08. | OSTEOPORE LIMITED: OSX completes first Hainan custom orthopaedic implant | 1 | ASX | ||
| 31.07. | OSTEOPORE LIMITED: Activities Report June 2026 and Appendix 4C | 1 | ASX | ||
| 23.07. | OSTEOPORE LIMITED: Application for quotation of securities - OSX | - | ASX | ||
| 14.07. | OSTEOPORE LIMITED: First OSX custom orthopaedic implant delivered to Hainan | - | ASX | ||
| OSTEOPORE Aktie jetzt für 0€ handeln | |||||
| 07.07. | OSTEOPORE LIMITED: OSX & Zimmer gain craniofacial market access to Saudi Arabia | - | ASX | ||
| 02.07. | OSTEOPORE LIMITED: OSX completes co-development project for neurosurgical guide | - | ASX | ||
| 30.06. | OSTEOPORE LIMITED: First patient treated in OSX-PAH jaw reconstruction trial | - | ASX | ||
| 29.06. | OSTEOPORE LIMITED: First 2 patients treated in QCH cleft lip clinical trial | - | ASX | ||
| 26.06. | Osteopore wraps up recruitment into 3D printing support for cleft lip patients | 1 | The Market Online Australia | ||
| 26.06. | OSTEOPORE LIMITED: QCH cleft lip clinical study patient recruitment completed | - | ASX | ||
| 24.06. | OSTEOPORE LIMITED: OSX neuro products approved in a major centre in Thailand | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Cleansing Notice | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Notification regarding unquoted securities - OSX | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Further Drawdown of T2 of the Redeemable Convertible Notes | - | ASX | ||
| 22.06. | OSTEOPORE LIMITED: First OSX custom orthopaedic implant completed in Hong Kong | - | ASX | ||
| 17.06. | OSTEOPORE LIMITED: OSX & DKSH Malaysia dental launch First products delivered | - | ASX |
1 2 3 4 Weiter >>
63 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 42,110 | +0,07 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| FRESENIUS | 47,080 | -1,22 % | EQS-News: Fresenius SE & Co. KGaA: Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
10.08.2026 / 14:30 CET/CEST
Für den... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,310 | +0,69 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,040 | +0,12 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,310 | -0,08 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,280 | +6,04 % | Märkte am Morgen: Boeing, Palo Alto, SAP, Infineon, Aixtron, TAG Immobilien, Südzucker, Carl Zeiss | Der DAX dürfte seinen Rekordkurs trotz verhaltener Wall-Street-Vorgaben verteidigen. Im Fokus stehen der wieder steigende Ölpreis, die niedrigen strategischen US-Reserven und die anhaltende Unsicherheit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,73 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 26,280 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,950 | -0,07 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,415 | 0,00 % | LifeStance Health gains as Hedgeye adds as new long idea | ||
| SANARA MEDTECH | 34,140 | -0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| BILLIONTOONE | 93,34 | +0,01 % | Diagnostiksektor: BTIG kürt BillionToOne zum Top-Pick | ||
| BETA BIONICS | 17,570 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GERRESHEIMER | 27,160 | +0,97 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| GENEDX | 78,16 | +0,10 % | GeneDx launches online exome testing for pediatric patients |
OSTEOPORE LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OSTEOPORE LIMITED finden Sie auf Wallstreet Online.